Company Filing History:
Years Active: 2023
Title: **Kwang Il Park: Innovator in Retinal Health**
Introduction
Kwang Il Park, an accomplished inventor based in Daegu, South Korea, has made significant strides in the field of pharmaceutical innovations. His notable contribution centers around the development of a unique pharmaceutical composition that harnesses the beneficial properties of maple leaf extract in the prevention and treatment of retinal diseases.
Latest Patents
Kwang Il Park holds a patent for a pharmaceutical composition comprising a maple leaf extract aimed at preventing or treating retinal disease. This invention includes a method for utilizing this composition effectively, as well as its application in formulating health functional foods intended to alleviate symptoms associated with retinal diseases. The innovation not only serves a pharmaceutical purpose but also displays potential for application in nutritional health.
Career Highlights
Kwang Il Park is affiliated with the Korea Institute of Oriental Medicine, where he has focused on developing medicinal breakthroughs that leverage traditional knowledge and modern scientific approaches. His role at this esteemed institution allows him to merge cultural heritage with innovative science, enhancing the potential impact of his work on global health.
Collaborations
Throughout his career, Kwang Il Park has collaborated with fellow researchers, including colleagues Jin Yeul Ma and Yeoun-Hee Kim. These collaborations have facilitated the sharing of ideas and expertise, contributing to successful research outcomes and advancements in their field.
Conclusion
Kwang Il Park's dedication to improving retinal health through innovative pharmaceutical compositions illustrates the significant role of inventors in addressing medical challenges. His work in utilizing maple leaf extract is a testament to the potential of nature-inspired solutions in modern medicine. As research continues, his contributions will likely pave the way for new treatments that enhance the quality of life for individuals suffering from retinal diseases.